Conversion from twice-daily prograf to once-daily advagraf in multi-ethnic asian adult renal transplant recipients with or without concomitant use of diltiazem - impact of CYP3A5 genetic polymorphism on tacrolimus pharmacokinetics
100
Saved in:
Main Authors: | Yau, Wai-Ping, Vathsala, Anantharaman |
---|---|
Other Authors: | MEDICINE |
Format: | Conference or Workshop Item |
Published: |
LIPPINCOTT WILLIAMS & WILKINS
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/229246 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
CONVERSION FROM TWICE-DAILY PROGRAF<SUP>®</SUP> TO ONCE-DAILY ADVAGRAF<SUP>®</SUP> IN MULTI-ETHNIC ASIAN ADULT RENAL TRANSPLANT RECIPIENTS WITH OR WITHOUT CONCOMITANT USE OF DILTIAZEM: IMPACT OF CYP3A5 AND MDR1 GENETIC POLYMORPHISMS ON TACROLIMUS EXPOSURE
by: Yau, WP, et al.
Published: (2019) -
The association between trough blood concentration and systemic exposure of tacrolimus: Comparison between once-daily (Advagraf®) and twice-daily (Prograf®) formulation in de novo kidney transplant recipients
by: Sayamon Sukkha, et al.
Published: (2020) -
Safety and efficacy of conversion from once daily Sandimmune to twice daily Neoral cyclosporine in renal allograft recipients
by: Vathsala, A, et al.
Published: (2022) -
Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study
by: Sayamon Sukkha, et al.
Published: (2018) -
Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial
by: Lionel Rostaing, et al.
Published: (2022)